119 related articles for article (PubMed ID: 31802038)
21. Subclinical Cushing's syndrome in adrenal incidentaloma.
Terzolo M; Osella G; Alì A; Borretta G; Cesario F; Paccotti P; Angeli A
Clin Endocrinol (Oxf); 1998 Jan; 48(1):89-97. PubMed ID: 9509073
[TBL] [Abstract][Full Text] [Related]
22. Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion.
Androulakis II; Kaltsas GA; Kollias GE; Markou AC; Gouli AK; Thomas DA; Alexandraki KI; Papamichael CM; Hadjidakis DJ; Piaditis GP
J Clin Endocrinol Metab; 2014 Aug; 99(8):2754-62. PubMed ID: 24712565
[TBL] [Abstract][Full Text] [Related]
23. Adrenal incidentaloma: a new cause of the metabolic syndrome?
Terzolo M; Pia A; Alì A; Osella G; Reimondo G; Bovio S; Daffara F; Procopio M; Paccotti P; Borretta G; Angeli A
J Clin Endocrinol Metab; 2002 Mar; 87(3):998-1003. PubMed ID: 11889151
[TBL] [Abstract][Full Text] [Related]
24. Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.
Vieira-Correa M; Giorgi RB; Oliveira KC; Hayashi LF; Costa-Barbosa FA; Kater CE
J Endocrinol Invest; 2019 Dec; 42(12):1435-1442. PubMed ID: 31456173
[TBL] [Abstract][Full Text] [Related]
25. The association of autoimmune thyroiditis and non-functional adrenal incidentalomas with insulin resistance.
Karakose M; Karbek B; Sahin M; Arslan MS; Topaloglu O; Erden G; Demirci T; Calıskan M; Delibasi T
Arch Endocrinol Metab; 2015 Feb; 59(1):42-6. PubMed ID: 25926113
[TBL] [Abstract][Full Text] [Related]
26. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
al-Saadi N; Diederich S; Oelkers W
Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
[TBL] [Abstract][Full Text] [Related]
27. Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship?
Peppa M; Boutati E; Koliaki C; Papaefstathiou N; Garoflos E; Economopoulos T; Hadjidakis D; Raptis SA
Metabolism; 2010 Oct; 59(10):1435-41. PubMed ID: 20153874
[TBL] [Abstract][Full Text] [Related]
28. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma.
Fernández-Real JM; Engel WR; Simó R; Salinas I; Webb SM
Clin Endocrinol (Oxf); 1998 Jul; 49(1):53-61. PubMed ID: 9797847
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of body composition using dual-energy X-ray absorptiometry in patients with non-functioning adrenal incidentalomas and an intermediate phenotype: Is there an association with metabolic syndrome?
Moraes AB; Cavalari EMR; de Paula MP; Arruda M; Curi DSC; Leitão RA; de Mendonça LMC; Farias MLF; Madeira M; Vieira Neto L
J Endocrinol Invest; 2019 Jul; 42(7):797-807. PubMed ID: 30465247
[TBL] [Abstract][Full Text] [Related]
30. The association of cortisol and adrenal androgen with trabecular bone score in patients with adrenal incidentaloma with and without autonomous cortisol secretion.
Kim BJ; Kwak MK; Ahn SH; Kim JS; Lee SH; Koh JM
Osteoporos Int; 2018 Oct; 29(10):2299-2307. PubMed ID: 29971455
[TBL] [Abstract][Full Text] [Related]
31. Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome.
Garrapa GG; Pantanetti P; Arnaldi G; Mantero F; Faloia E
J Clin Endocrinol Metab; 2001 Nov; 86(11):5301-6. PubMed ID: 11701696
[TBL] [Abstract][Full Text] [Related]
32. Cushing's syndrome: comparison between Cushing's disease and adrenal Cushing's.
Hirsch D; Shimon I; Manisterski Y; Aviran-Barak N; Amitai O; Nadler V; Alboim S; Kopel V; Tsvetov G
Endocrine; 2018 Dec; 62(3):712-720. PubMed ID: 30084101
[TBL] [Abstract][Full Text] [Related]
33. The Role of Cortisol/ACTH Ratio for Screening of Subclinical Hypercortisolism in Patients with Adrenal Incidentalomas.
Li L; Yang G; Dou J; Gu W; Lv Z; Lu J; Mu Y
Exp Clin Endocrinol Diabetes; 2018 Feb; 126(2):71-76. PubMed ID: 28931176
[TBL] [Abstract][Full Text] [Related]
34. Hormonal and metabolic rhythms in Cushing's syndrome.
Johnston DG; Alberti KG; Nattrass M; Barnes AJ; Bloom SR; Joplin GF
Metabolism; 1980 Oct; 29(11):1046-52. PubMed ID: 7001175
[TBL] [Abstract][Full Text] [Related]
35. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study.
Di Dalmazi G; Vicennati V; Rinaldi E; Morselli-Labate AM; Giampalma E; Mosconi C; Pagotto U; Pasquali R
Eur J Endocrinol; 2012 Apr; 166(4):669-77. PubMed ID: 22267278
[TBL] [Abstract][Full Text] [Related]
36. Serum Amyloid A, Paraoxonase-1 Activity, and Apolipoprotein Concentrations as Biomarkers of Subclinical Atherosclerosis Risk in Adrenal Incidentaloma Patients.
Imga NN; Topcuoglu C; Berker D; Turhan T
Arch Med Res; 2018 Apr; 49(3):182-190. PubMed ID: 30031631
[TBL] [Abstract][Full Text] [Related]
37. Patients with extra-adrenal malignancies and adrenal lesions have similar rates of subclinical hypercortisolism compared with patients with true adrenal incidentalomas.
Chrisoulidou A; Rakitzi P; Boudina M; Apostolidou-Kiouti F; Poimenidou E; Papanikolaou A; Devlioti A; Rallis G; Pazaitou-Panayiotou K
Hormones (Athens); 2019 Mar; 18(1):85-89. PubMed ID: 30737657
[TBL] [Abstract][Full Text] [Related]
38. The prevalence and characteristics of non-functioning and autonomous cortisol secreting adrenal incidentaloma after patients' stratification by body mass index and age.
Podbregar A; Janez A; Goricar K; Jensterle M
BMC Endocr Disord; 2020 Jul; 20(1):118. PubMed ID: 32736549
[TBL] [Abstract][Full Text] [Related]
39. Elevated plasma endothelin as an additional cardiovascular risk factor in patients with Cushing's syndrome.
Kirilov G; Tomova A; Dakovska L; Kumanov P; Shinkov A; Alexandrov AS
Eur J Endocrinol; 2003 Dec; 149(6):549-53. PubMed ID: 14640996
[TBL] [Abstract][Full Text] [Related]
40. Lipid abnormalities in patients with adrenal incidentalomas: role of subclinical hypercortisolism and impaired glucose metabolism.
Masserini B; Morelli V; Palmieri S; Eller-Vainicher C; Zhukouskaya V; Cairoli E; Orsi E; Beck-Peccoz P; Spada A; Chiodini I
J Endocrinol Invest; 2015 Jun; 38(6):623-8. PubMed ID: 25608646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
